EC Number   |
Inhibitors |
Structure |
|---|
   1.14.11.63 | 2-[(3-fluoro-3'-methoxy[1,1'-biphenyl]-4-yl)carbamoyl]cyclopent-1-ene-1-carboxylic acid |
- |
 |
| 1.14.11.63 | 2-[3-(3,4-dimethoxyphenyl)propanamido]benzoic acid |
- |
|
| 1.14.11.63 | 3-amino-N-[3-(4-amino-4-methylcyclohexyl)pyridin-2-yl]-6-[3-(trifluoromethyl)pyridin-2-yl]-2,3-dihydropyrazine-2-carboxamide |
- |
|
| 1.14.11.63 | 5-(1,3-benzothiazol-2-yl)-N-propylthiophene-2-carboxamide |
- |
|
| 1.14.11.63 | 7-[phenyl[(pyridin-2-yl)amino]methyl]quinolin-8-ol |
- |
  |
| 1.14.11.63 | ethyl 2-[[(4-nitrophenyl)methanesulfonyl]carbamoyl]pyridine-4-carboxylate |
- |
|
| 1.14.11.63 | [8-[(2,4-dichlorobenzoyl)oxy]quinolin-5-yl]azinic acid |
compound efficiently binds to JMJD7 in vitro. In a cellular assay, the compound displays good inhibitory activity against cancer cell lines expressing a high level of JMJD7 |
|
